Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8076503 | 0.83 | CHRM1 (0.59) | CHRM1 | |
| SCHEMBL8068625 | 0.78 | CHRM1 (0.53) | CHRM1CHRM2 | |
| SCHEMBL14507228 | 0.74 | CHRM1 (0.45) | CHRM1 | |
| SCHEMBL7810254 | 0.64 | CHRM1 (0.57) | CHRM1CHRM2 | |
| SCHEMBL7272156 | 0.63 | CHRM1 (0.42) | CHRM1 | |
| SCHEMBL7272311 | 0.62 | CHRM1 (0.44) | CHRM1 | |
| SCHEMBL7270883 | 0.62 | CHRM1 (0.44) | CHRM1 | |
| Hydrochloric Acid SCHEMBL7279918 | 0.62 | CHRM1 (0.41) | CHRM1 | |
| Hydrochloric Acid SCHEMBL7279968 | 0.61 | CHRM1 (0.43) | CHRM1 | |
| Hydrochloric Acid SCHEMBL7278417 | 0.61 | CHRM1 (0.43) | CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998434-A | Composition for treating pain | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | claimed |
| EP-0874828-A4 | COMPOSITION FOR TREATING PAIN | LILLY CO ELI (US) | 1999-09-01 | — | — | EP | claimed |
| EP-0874828-A1 | COMPOSITION FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1998-11-04 | — | — | EP | claimed |
| WO-1997020819-A1 | COMPOSITION FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1997-06-12 | — | — | WO | claimed |
| EP-0788489-A4 | HETEROCYCLIC COMPOUNDS AND THEIR USE | LILLY CO ELI (US) | 2000-11-15 | — | — | EP | disclosed |
| US-6071900-A | 2-AZABICYCLOOXYPYRIDAZINES TO TREAT DISEASES IN THE CENTRAL NERVOUS SYSTEM CAUSED BY MALFUNCTIONING OF THE MUSCARINIC CHOLINERGIC SYSTEM; ALZHEIMER'S DISEASE; ANALGESICS; GI AND SLEEPING DISORDERS; GLAUCOMA, PSYCHOSIS, ANTIDEPRESSANTS | ELI LILLY AND COMPANY (US) | 2000-06-06 | — | — | US | disclosed |
| US-6030966-A | FOR TREATING ALZEHIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5998404-A | NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| US-5998434-A | Composition for treating pain | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0788489-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE | ELI LILLY AND COMPANY (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1997017956-A1 | METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1997-05-22 | — | — | WO | disclosed |
| EP-0773021-A1 | Use of azacyclic or azabicyclic oxadiazole compounds for treating anxiety | ELI LILLY AND COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| US-5605908-A | TREATING DISEASES OF CENTRAL NERVOUS SYSTEM CAUSED BY MALFUNCTIONING OF MUSCARINIC CHOLINERGIC SYSTEM | ELI LILLY AND COMPANY (US) | 1997-02-25 | — | — | US | disclosed |
| WO-1996012711-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE | ELI LILLY AND COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |